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apoAbstract—Adequate cellular transport of ascorbic acid (AA) and its oxidation product dehydroascorbate (DHA) is
assured through specific carriers. It was shown that vitamin C is taken up as DHA by most cell types, including cancer
cells, via the facilitative GLUT transporters. Thus, AA oxidation to DHA can be considered a mechanism favoring
vitamin C uptake and intracellular accumulation. We have investigated whether such an AA-oxidizing action might be
provided by plasma membrane g-glutamyltransferase (GGT), previously shown to function as an autocrine source of
prooxidants. The process was studied using two distinct human metastatic melanoma clones. It was observed that the
Me665/2/60 clone, expressing high levels of membrane GGT activity, was capable of effecting the oxidation of
extracellular AA, accompanied by a marked increase of intracellular AA levels. The phenomenon was not observed with
Me665/2/21 cells, possessing only traces of membrane GGT. On the other hand, AA oxidation and stimulation of cellular
uptake were indeed observed after transfection of 2/21 cells with cDNA coding for GGT. The mechanism of GGT-
mediated AA oxidation was investigated in acellular systems, including GGT and its substrate glutathione. The process
was observed in the presence of redox-active chelated iron(II) and of transferrin or ferritin, i.e., two physiological iron
sources. Thus, membrane GGT activity—often expressed at high levels in human malignancies—can oxidize
extracellular AA and promote its uptake efficiently. D 2004 Elsevier Inc. All rights reserved.
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Ascorbic acid (AA) plays essential roles in living
organisms as effective antioxidants in scavenging reac-
tive oxygen species (ROS) and as an important cofactors
in various enzymatic reactions [1]. Such physiological
functions of ascorbic acid are associated with its
oxidation, leading to the formation of ascorbate free
radicals which are then converted to the divalent
oxidation product dehydroascorbate (DHA) through
disproportionation or further oxidation. Several dehy-1906
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capable of reducing DHA again to ascorbic acid, the
physiologically active form of vitamin C [2–6]. Two such
activities have been purified and characterized in our
laboratories, using either GSH [3,6] or NADPH [4] as
donors of reducing equivalents. DHA reduction repre-
sents a crucial mechanism to maintain steady state
concentrations of ascorbic acid within the cell, despite
a constant loss of the reduced molecule following
oxidation by free radicals. This role becomes even more
important in conditions of oxidative stress, when large
amounts of free radicals are produced.
At the plasma membrane level two systems—Na+-
dependent cotransport of ascorbate and facilitated
diffusion of dehydroascorbate—have been described
[7,8]. In particular, it was shown that vitamin C is
taken up by most cell types, including cancer cells, in
the oxidized form as DHA, via the facilitative hexose
transporters (GLUTs) [9]. Once in the intracellularFree Radical Biology & Medicine, Vol. 37, No. 11, pp. 1906–1915, 2004
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Vitamin C uptake through g-glutamyltransferase 1907compartment, DHA can undergo reduction by DHA
reductases; facilitated DHA transport therefore repre-
sents an important mechanism for cellular vitamin C
supply [9,10]. In this perspective, processes leading to
the oxidation of ascorbic acid to DHA in the cellular
microenvironment can be considered mechanisms favor-
ing vitamin C uptake and intracellular accumulation. A
rapid and efficient AA uptake has been described in
several cancer cell lines in vitro [10,11], though the
phenomenon has not yet been explained. It has been
suggested that in tumor stroma some activities capable
of favoring the transformation of ascorbate to DHA and
its subsequent uptake through GLUT transporters may
exist [12].
Against this background and based on previous
results obtained in our laboratories, the present study
was aimed to determine whether such an AA-oxidizing
action might be provided by plasma membrane g-
glutamyltranspeptidase (GGT). We have in fact previ-
ously shown that membrane GGT activity is an autocrine
source of ROS and other free radicals, capable of
promoting prooxidant reactions in the cellular micro-
environment [13,14]. GGT, having its active site oriented
toward the outer cell surface, is the only enzymatic
activity capable of cleaving extracellular glutathione
(GSH), thus originating precursor amino acids for the
intracellular resynthesis of GSH [15]. In so doing, GGT
participates in a sort of bGSH cyclingQ across the plasma
membrane, since a continuous efflux of reduced GSH
has been described in most cell types through ubiq-
uitously expressed, specific GSH transporter proteins
[16]. GGT activity is often present in high levels in many
human spontaneous neoplasms, both primitive and
metastatic (carcinomas of ovary, colon, liver; sarcoma;
leukemias; melanoma) [17–19]. Previous work in our
laboratory has shown that GGT can exert a bprooxidantQ
action in the extracellular space [13,20–22]. At the
extracellular level, GGT-mediated catabolism of GSH in
fact leads to the formation of the dipeptide cysteinyl-
glycine, whose –SH group is provided with high
reactivity in the first place with transition metal ions,
e.g., ferric iron ions:
GSH---GGT--Nglutamic acidþ gly-cys-Sþ Hþ ð1Þ
gly-cys-S þ Fe3þ---Ngly-cys-SS þ Fe2þ ð2ÞAt neutral pH, this biron-reducingQ ability is rather
low in GSH while it is high in cysteinyl-glycine and
cysteine [23,24]. Since it indeed transforms GSH into
these molecules, GGT activity is thus a factor favoring
the reduction of transition metal ions present in theextracellular microenvironment. Studies in our labora-
tories have documented that the biron-reducingQ ability
of GGT can in turn give rise to radical processes,
leading to the formation of reactive oxygen species
(superoxide anion, hydrogen peroxide) and other
radicals:
Fe2þ þ O2---NFe3þ þ O S2 ðsuperoxide anionÞ ð3Þ
O S:2 þ 2 H2O---N1=2 O2 þ 2 Hþ þ H2O2
ðhydrogen peroxideÞ ð4Þ
Thus, in the presence of GSH fluxes which normally
occur across the plasma membrane of cells, extracellular
GGT activity is continuously supplied with substrate
(GSH) and originates reactive GSH metabolites, reactive
oxygen species, and other radicals in the extracellular
microenvironment.
The data reported in the present study indicate that
membrane GGT activity can oxidize extracellular AA
and promote its cellular uptake efficiently. The expres-
sion of membrane GGT appears thus to represent an
(additional) mechanism for vitamin C replenishment in
cancer cells, a phenomenon liable to result in increased
resistance to oxidative injury induced by a number of
agents, including some important anticancer drugs.
EXPERIMENTAL PROCEDURES
Chemicals
Unless otherwise indicated, all reagents were from
Sigma Chemical Co. (St. Louis, MO, USA).
Cell culture and treatments
Two different cell clones derived from the same
subcutaneous metastasis of human melanoma, Me665/
2/60 (bc60 cellsQ) and Me665/2/21 cells (bc21 cellsQ),
expressing high and low to trace levels of GGT activity,
respectively, were used. Cells were grown in RPMI
1640 medium supplemented with 5% (v/v) heat-
inactivated fetal calf serum and 2 mM l-glutamine, at
378C in a 5%/95% CO2/air atmosphere.
For treatments, RPMI medium was replaced with
HanksT buffer, pH 7.4, and the following agents were
added (final concns.): ascorbic acid (0.5 mmol/L), GSH
(0.5 mmol/L), glycyl-glycine (20 mmol/L), and ADP-
chelated FeCl3 (200–20 Amol/L). Incubations were started
by adding ADP-Fe(III) to incubation mixtures, in the
presence or absence of glycyl-glycine; the latter served as
acceptor for transpeptidation and was added to stimulate
GGT activity [25]. Inhibition of GGT activity was
obtained by treating cells with noncompetitive inhibitor
AT125 (1 mmol/L) for 60 min prior to incubation.
A. Corti et al.1908In selected experiments, HanksT buffer was replaced
with a 10 mmol/L Hepes/phosphate buffer, pH 7.4,
containing 147 mmol/L NaCl, 5 mmol/L KCl, 1.9
mmol/L KH2PO4, 1.1 mmol/L Na2HPO4, 5.5 mmol/L
glucose, 0.3 mmol/L MgSO4:7H2O, 1 mmol/L
MgCl2:6H2O, and 0.3 mmol/L CaCl2:2H2O. Forsodium-free buffer, NaCl and Na2HPO4 were replaced
by choline chloride and K2HPO4.
In GGT-poor c21 cells, GGT activity was increased by
transiently transfecting cells with a vector (pcDNA;
Invitrogen) containing GGT cDNA. A lipid transfection
according to Lipotaxi mammalian transfection kit proto-
col (Stratagene) was used.
AA concentration was determined by high-pressure
liquid chromatography, according to Rose and Bode [26].
At the established times, incubation mixtures were
extracted with 5% (w/v) trichloroacetic acid (Fluka)
and then diluted in 50 mM phosphoric acid (J.T. Baker);
20-Al aliquots were injected in a C-18 reverse-phase
column (Resolve; Waters, USA). The mobile phase (0.2
M KH2PO4/H3PO4, pH 3.0) was delivered at a flow rate
of 1 mL/min, and ascorbate was detected by an electro-
chemical detector (ESA Coulochem III) with a Model
5011 analytical cell. Determinations were performed at
potentials of –0.35/0.2 V applied on upstream and
downstream electrode, respectively.
GSH determinations were performed using the enzy-
matic method described by Baker et al. [27] adapted to
the microtiter plate reader. Other experimental details are
given in legends to individual figures.
Preparation of holo-transferrin and ferritin
In experiments including human holo-transferrin or
ferritin as sources of redox-active iron, prior to use both
proteins were purified through a column of Chelex-100
resin to remove loosely/aspecifically bound Fe3+[28].
Mechanism of ascorbic acid oxidation
Incubations (2 mL) were carried out in 100 mM Tris–
HCl buffer, pH 7.4, at 378C and contained ascorbic acid
(5 mmol/L), GSH (0.5 mmol/L), ADP-chelated FeCl3
(final concn.: 200 Amol/L chelator–20 Amol/L FeCl3;
stock solution was freshly prepared at least 15 min prior
to use), and GGT (100 mU/mL). Glycyl-glycine was also
present in the incubations (20 mmol/L), serving as
acceptor for the GGT-mediated transpeptidation reaction.
Nonenzymatic oxidation of AA was started by adding
ADP-Fe(III) to the incubation mixtures. Enzymatic
oxidation was started by adding ADP-Fe(III) plus GGTig. 1. Role of GGTactivity in the uptake of ascorbic acid (AA) by GGT-
ch Me665/2/60 human melanoma cells. Cells were incubated up to 120
in at 378C inHanks’ buffer (pH 7.4) containingAA (0.5mmol/L), GSH
.5 mmol/L), and ADP-Fe(III) (200 Amol/L chelator–20 Amol/L FeCl3).
ell-associated GGT activity wasc26 mU/mg protein. Reactions were
arted by adding ADP-Fe, in the presence or absence of glycyl-glycine
0 Amol/L). Where indicated, cells were treated prior to incubation with
e irreversible GGT inhibitor, AT125 (1 mmol/L), for 60 min. (A) Time
ourse of extracellular GSH concentration; (B) time course of extrac-
llular AA concentration; (C) intracellular AA concentrations after 120
in of incubation. Results are meansF SD of three separate experiments.
ata were analyzed by two-wayANOVA. (n.s.) Not statistically different













Vitamin C uptake through g-glutamyltransferase 1909at the same time. All components were freshly prepared
and kept on ice until used. AA and GSH determinations
were performed as described above.
In separate sets of experiments the following anti-
oxidants were used: erythrocyte CuZn/SOD (500 U/mL),
thymol-free liver catalase (400 U/mL), mannitol (10
mM). Where indicated, the iron chelator deferoxamine
mesylate (DFO; 3 mM) was also employed. Inhibition of
GGT activity was obtained with the competitive inhibitor
serine/boric acid (20/20 mM) complex (SEB), added to
incubations simultaneously with GGT.Other determinations
Protein content was determinated by the method of
Bradford (Bio-Rad protein assay). Cell viability was
routinely controlled by the trypan blue exclusion test.
GGT activity was determinated spectrophotometrically
using g-glutamyl-p-nitroanilide as substrate, according to
Huseby and Strfmme [25]. Statistical analysis of data
was performed by ANOVA, with Neuman–Keuls test for
multiple comparisons.
RESULTS
GGT-dependent facilitation of AA uptake in Me665/2
human melanoma cells
Two distinct clones of human melanoma cells,
exhibiting largely different intrinsic GGT activities, were
compared; in addition, GGT-coding cDNA was trans-
fected in the low-GGT clone. Fig. 1 reports results
obtained with GGT-rich Me665/2/60 cells, presenting
with c26 mU/mg cellular protein. As can be seen, the
stimulation of cellular GGT activity by adding the
transpeptidation substrate glycyl-glycine to the incuba-
tion medium produced a marked acceleration of GSH
consumption (Fig. 1A), along with a marked stimulation
of AA oxidation (Fig. 1B). When the intracellular
concentrations of AA were assayed, at the latest time of
incubation (120 min), it was indeed found that AA
uptake was much higher in cells stimulated with glycyl-
glycine; the effect was totally prevented in cells whose
GGT activity had been irreversibly inhibited with AT125
(Fig. 1C). Accordingly, AT125 pretreatment of cells was
observed to suppress both GSH consumption and AA
oxidation (not shown).
In experiments with GGT-poor c21 cells, i.e., cells
exhibiting c0.2 mU GGT/mg protein, the addition of
glycyl-glycine essentially produced none or minor effects
on GSH consumption, AA oxidation rate, or AA intra-
cellular concentrations (Figs. 2A–2C). The c21 cells wereig. 2. GSH consumption, extracellular oxidation of ascorbic acid
AA), and AA uptake after transient transfection of GGT in GGT-poor
e665/2/21 human melanoma cells. Cells were transiently transfected
ith a vector containing GGT cDNA (pcDNA3-GGT), while controls
ere obtained by transfecting cells with the vector without GGT
DNA (pcDNA3). At 48 h from transfection, GGT activity was c0.2
U/mg protein in control vs c30 mU/mg protein in pcDNA-GGT
ansfected cells. Cells were incubated up to 120 min at 378C in
anks’ buffer (pH 7.4) containing AA (0.5 mmol/L), GSH (0.5 mmol/
), ADP-Fe (III) (200 Amol/L chelator–20 Amol/L FeCl3). Reactions
ere started by adding ADP-Fe (III), in the presence or absence of
lycyl-glycine (20 mmol/L). (A) Time course of extracellular GSH
oncentration; (B) time course of extracellular AA concentration; (C)
tracellular AA concentrations after 120 min of incubation: a,
ontrols (cells transfected with empty vector); b, cells transfected
ith pcDNA-GGT vector; c, GGT-stimulated controls; d, GGT-
timulated transfected cells. Results are means F SD of three separate


















compared with pcDNA-GGT; (**) p b 0.001 compared with control.
Fig. 3. GSH/GGT-dependent oxidation and cellular uptake of ascorbic acid (AA): effects of glucose and cytochalasin. Melanoma
Me665/2/60 cells were incubated for 120 min at 378C in HanksT buffer (pH 7.4) containing AA (0.5 mmol/L), GSH (0.5 mmol/L), and
ADP-Fe(III) (200 Amol/L chelator–20 Amol/L FeCl3). Glycyl-glycine (20 Amol/L) was added to stimulate GGT activity. (A,B) Control
incubations; (C,D) incubations performed in the presence of high glucose concentrations (5 g/L); (E,F) incubations performed in the
presence of cytochalasin B (20 Amol/L). Results are means F SD of three separate determinations. Data were analyzed by ANOVAwith
Student–Newman–Keuls multiple comparisons test. (*) p b 0.05 compared with corresponding control; (**) p b 0.05 compared with
corresponding low-glucose samples (B).
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Table 2. Effects of GGT Inhibition, Iron Chelation, and Reactive
Oxygen Scavenging on GSH/Iron(III)-Dependent Oxidation of
Ascorbic Acid (AA) in Acellular Systems
amples
AA (% of 0-time
concentration)
ontrol 97.0 F 0.8
GGT 95.8 F 5.9 (n.s.)
ADPFe 57.2 F 1.2 (y)
GGT+ ADPFe 14.9 F 1.5 (z)
GGT+ ADPFe+ SEB 61.1 F 4.0 (*)
GGT+ ADPFe+ DFO 98.9 F 3.0 (*)
GGT+ ADPFe+ SOD 34.8 F 0.1 (*)
GGT+ ADPFe+ CAT 27.6 F 0.1 (*)
GGT+ ADPFe+ SOD+ CAT 42.2 F 3.2 (*)
Note. Incubations (2 mL final volume) were carried out for 60 min at
78C in Tris–HCl pH (7.4) and contained AA (0.5 mmol/L), GSH
0.5 mmol/L), glycyl-glycine (20 mmol/L). Reactions were started by
dding ADP-Fe (final concn.: 100–10 Amol/L, of chelator–FeCl3,
espectively), in presence or absence of purified GGT (100 mU/mL).
here indicated, serine/boric acid (SEB; 20/20 mmol/L), deferoxamine
esylate (DFO; 3 mmol/L), superoxide dismutase (SOD; 500 U/mL),
r catalase (CAT; 400 U/mL) were also added to incubations. Data are
eans F SD of three separate determinations. Data were analyzed by
NOVAwith Student–Newman–Keuls multiple comparisons test. (n.s.)
ot statistically different from control; (y) p b 0.001 compared with
ontrol; (z) p b 0.001 compared with ADPFe; (*) p b 0.001 compared
ith +GGT+ADPFe.
Vitamin C uptake through g-glutamyltransferase 1911then transfected with GGT. At 48 h after transfection with
pcDNA-GTT vector, GGT activity rose to c30 mU/mg
protein, as compared with only c0.2 mU/mg in control
(sham-transfected) cells. The stimulation of GGT-trans-
fected c21 cells with glycyl-glycine indeed produced a
facilitation of AA oxidation in the culture medium, while
extracellular GSH was progressively consumed (Figs. 2A
and 2B). At later times of incubation, the intracellular
content of AA after glycyl-glycine stimulation was nearly
twice higher in GGT-transfected cells, as compared to the
parent cell line transfected with an empty vector (Fig. 2C).
Membrane transporters involved in GGT-facilitated
cellular AA uptake
Experiments were carried out to verify the involvement
of GLUT transporters in GGT-stimulated uptake of AA in
Me665/2/60 cells (Fig. 3). When incubations were
performed in the presence of high glucose concentration
(5 g/L), while extracellular oxidation of AA was unaf-
fected, a significantly lower AA uptake was observed both
before and after GGT activation by glycyl-glycine (Fig.
3D), indicating competition for transport by glucose. In
the presence of cytochalasin B, added as an inhibitor of
GLUT-mediated transport, complete suppression of AA
uptake was observed, despite extracellular AA oxidation
not being affected (Figs. 3E and 3F).
Further experiments were aimed to verify the possible
involvement of sodium-dependent vitamin C transpor-
ters. As reported in Table 1, incubation of cells in
sodium-free conditions did not produce significant
modifications of the intracellular AA uptake.
Mechanisms of GGT-mediated AA oxidation
Table 2 reports data obtained in acellular systems
including purified GGT, glutathione, and glycyl-glycine.
Efficient oxidation of AA was observed only when ironTable 1. GSH/GGT-Dependent Oxidation and Cellular Uptake of







Control 83.0 F 0.6 28.7 F 2.3
Control+ gly-gly 37.7 F 1.4 128.0 F 3.5
Sodium-free 94.1 F 2.5 25.6 F 3.2 (n.s.)
Sodium-free+ gly-gly 39.8 F 0.3 135.1 F 11.2 (n.s.)
Note. Me665/2/60 melanoma cells were incubated for 120 min at
378C in Hepes/phosphate buffer, pH 7.4. For sodium-free incubations,
NaCl and Na2HPO4 were replaced with choline chloride and KHPO4.
Incubations contained AA (0.5 mmol/L), GSH (0.5 mmol/L), and ADP-
Fe(III) (200 Amol/L chelator–20 Amol/L FeCl3). Where indicated,
glycyl-glycine (20 Amol/L) was added to stimulate GGT activity. Data
are means F SD of three separate determinations. Data were analyzed
by ANOVA with Student–Newman–Keuls multiple comparisons test.





















wions were also present in the incubation, added in the
form of complexes with ADP. The GGT inhibitor SEB
produced a marked inhibition of AA oxidation, along
with inhibition of GSH consumption (not shown). The
iron chelator DFO completely prevented AA oxidation,
both in the absence (not shown) and in the presence of
GGT activity. GSH consumption was unaffected by
DFO, indicating that GGT activity itself was not
disturbed by DFO addition (not shown). A marked
inhibition of GGT-induced AA oxidation was obtained
with SOD, CAT, and a mixture of the two enzymes
(Table 2). On the other hand, mannitol, a scavenger of
hydroxyl radicals, allowed no protection on AA oxida-
tion (data not shown), indicating that hydroxyl radicals
are not involved.
The role of iron in GGT-facilitated cellular uptake of
AA was further investigated in experiments reported in
Table 3. In the absence of exogenously added iron GGT
activation by glycyl-glycine did not significantly stimu-
late cellular AA uptake. On the other hand, GGT
stimulation of cellular AA uptake was well evident after
the addition of ADP-chelated iron; the latter also induced
an increase of AA uptake in control cells, in the absence
of glycyl-glycine.
The possibility that iron ions required by the reaction
could be provided by physiological sources of iron was
investigated in experiments including human holo-trans-
ferrin or ferritin (Fig. 4). Indeed, AA oxidation was also
observed when ADP-Fe was substituted with human
Fig. 5. Oxidation of ascorbic acid (AA) in the presence of the GGT-
derived GSH catabolite, cysteinyl-glycine. Experiments were performed
at 378C in Tris–HCl (pH 7.4) andmixtures (2 mL final volume) contained
AA (0.5 mmol/L), GSH (0.5 mmol/L), glycyl-glycine (20 mmol/L), and
ADP-Fe (III) (200 Amol/L chelator–20 Amol/L FeCl3). Reactions were
started by addingADP-Fe (III).Where indicated, GGT (100mU/mL) and
cysteinyl-glycine (0.5 mmol/L) were added. Results are means F SD of
three separate experiments. Data were analyzed by two-wayANOVA. (*)
p b 0.001 compared with control.
Table 3. The Role of Iron in GSH/GGT-Dependent Cellular Uptake of







Control 84.4 F 3.5 6.4 F 0.3
+gly-gly 84.8 F 1.6 7.7 F 1.5 (n.s.)
+ADP-Fe 84.5 F 3.2 21.4 F 3.0 (*)
+ADP-Fe+ gly-gly 35.4 F 0.2 150.2 F 1.1 (**)
+DFO 87.8 F 1.1 6.0 F 0.2 (n.s.)
+DFO+ gly-gly 88.6 F 0.8 6.5 F 0.2 (n.s.)
Notes. Cells were incubated for 120 min at 378C in HanksT buffer
(pH 7.4) containing AA (0.5 mmol/L) and GSH (0.5 mmol/L). Where
indicated, ADP-Fe(III) (200 Amol/L chelator–20 Amol/L FeCl3), glycyl-
glycine (20 Amol/L), or deferoxamine mesylate (DFO; 3 mmol/L) were
also added. Data are meansF SD of three separate determinations. Data
were analyzed by ANOVA with Student–Newman–Keuls multiple
comparisons test. (n.s.) Not statistically different from control; (*) p b
0.05 compared with control; (**) p b 0.05 compared with +gly-gly
sample.
A. Corti et al.1912holo-transferrin as the sole source of redox-active iron,
and the addition of GGT to incubations caused a marked
enhancement of this effect (Fig. 4A). When human
ferritin was used as iron source, this was enough to
promote AA oxidation, confirming data previously
reported by others [29]; as already observed with holo-
transferrin, the presence of GGT resulted in a marked
stimulation of AA oxidation (Fig. 4B).
The observations above suggested that the facilitation
effect on AA oxidation is produced by (thiol) metabolites
originating from GSH cleavage effected by GGT. This
was verified in experiments in which soluble GGT wasFig. 4. Role of holo-transferrin (hTf) and ferritin (FT) as sources of iron
oxidation. Incubations (0.5–2 mL final volumes) were carried out at 378
use, hTf and FT were prepared as reported under Experimental proced
glycine (20 mmol/L), and GGT (100 mU/mL), as indicated. Reaction
Results are means F SD of three separate experiments. Data were analy
gly+GSH; (**) p b 0.05 compared with GSH+gly-gly+FT; (***) p breplaced with cysteinyl-glycine, i.e., the dipeptide thiol
originated by GGT after the removal of glutamic acid
from GSH. As reported in Fig. 5, the addition to
incubation mixtures of cysteinyl-glycine was by itself
capable of mimicking the facilitation effect observed
with GGT activity, suggesting that cysteinyl-glycine mayfor the facilitation effect of GGT activity on ascorbic acid (AA)
C in Tris–HCl (pH 7.4) and contained AA (0.5 mmol/L). Prior to
ures. Incubation mixtures contained GSH (0.5 mmol/L), glycyl-
s were started by addition of (A) hTf, 5 AM or (B) FT, 1 AM.
zed by two-way ANOVA. (*) p b 0.05 compared with hTf+gly-
0.001 compared with GSH+gly-gly+FT.
Vitamin C uptake through g-glutamyltransferase 1913be the molecular species responsible for the effect
observed in incubations containing ADP-Fe, GSH, and
GGT activity.DISCUSSION
Several reports suggest that ascorbic acid can
contribute to the malignant phenotype of tumor cells,
by increasing their resistance to prooxidant agents and
chemotherapeutic drugs. Several tumors can readily take
up vitamin C in vitro [10–12], and a higher vitamin C
concentration has been demonstrated in breast cancer
cells than in the adjacent normal tissue [30]. In cultured
Nb2 rat lymphoma cells, tumor progression seems to be
associated with an enhanced ability to maintain ascor-
bate in its reduced form [31]. In LY-as cells, deriving
from a mouse B cell lymphoma, the development of
chemoresistance is associated with the overexpression
of a protein showing an elevated homology (81%) with
rat DHAR [32]. AA levels were found to be signifi-
cantly higher in adriamycin-resistant MCF-7 breast
tumor cells than in their adriamycin-sensitive counter-
parts [33].
The acquirement by tumor cells of additional mech-
anisms capable of facilitating their AA uptake could
provide them with a further selective advantage and
features of increased malignancy. The results presented
in this study indicate that one such additional mechanism
can coincide with the prooxidant reactions originated
from the activation of GGT activity at the surface of cells.
Such reactions in fact produce a facilitating effect on the
iron-dependent oxidation of ascorbic acid present in the
extracellular environment. The effect was dependent on
the amount of GGT enzyme present in the incubation
system and was suppressed by agents capable of
inhibiting enzyme activity. The facts that addition of
glucose to incubations caused a decrease in AA uptake
and that cytochalasin B completely suppressed it indicate
that indeed GLUT transporters are involved in the
process. On the other hand, no role for sodium-dependent
transport in incubations carried out in sodium-free media
was observed.
The results of experiments with mannitol and the
antioxidant enzymes SOD and CAT point to an involve-
ment of ROS—superoxide anion, hydrogen peroxide, but
not hydroxyl radical—in the process and suggest that
GGT may act by enhancing thiol-dependent ADP-iron
reduction and redox interactions with molecular oxygen
(redox cycling). Oxidation of AA in the medium was
promoted also by cell-associated GGT activity and in this
case the phenomenon was accompanied by a facilitation
of cellular uptake of ascorbic acid, allegedly in the form
of DHA produced during GGT-mediated extracellular
oxidations. In this respect, the characteristics of GGT-dependent AA oxidation and subsequent cellular uptake
make it fully comparable with analogous phenomena
described with activated phagocytes. It has in fact been
shown that the reactive oxygen species produced during
the respiratory burst of neutrophils can efficiently
promote vitamin C uptake and recycling in the activated
cells [34,35] and, importantly, in neighboring cells via a
bystander effect [35].
Chelated iron was also required for the GGT effect,
and this raises the question whether redox-active iron
may be available to cells for the described reactions to
take place. In this respect, the results of experiments
carried out with transferrin or ferritin as sources of
catalytic iron document that both storage forms of iron
can efficiently sustain GGT-dependent oxidation of
ascorbic acid. Concentrations of transferrin used were
below the range of those occurring in serum. The higher
concentrations used in the case of ferritin may be easily
reached at sites of cellular destruction, a condition
usually associated with invasive tumors. The catalytic
action of transferrin and ferritin in prooxidant reations is
a known phenomenon [36,37], and ferritin in particular
has been reported to stimulate ascorbate oxidation [29].
Indeed, previous work from our laboratory verified that
GGT-dependent reactions are able to produce the
delocalization of redox-active iron(II) ions from the
transferrin-bound pool [14]. It can be hypothesized that a
catalytic role of the same kind may be played by other
divalent cations, e.g., copper contained in ceruloplasmin.
Indeed, involvement of copper ions in GGT-dependent
generation of prooxidants has been described [38].
It has been shown that tumor cells can obtain vitamin
C from the medium by inducing the oxidation of AA to
DHA, i.e., the molecule capable of crossing plasma
membrane through the GLUT transporters, and such
oxidation has been ascribed to NADPH oxidase acti-
vities present in nonmalignant stromal cells [12]. In
addition to phagocytic cells, fibroblasts and endothelial
cells in fact are known to express constitutive NADPH
oxidase activity [39,40]. On the other hand, an
endogenous production of reactive oxygen species has
been observed in several cancer cell types [41,42],
including melanoma [43], in which it was attributed to
prooxidant reactions taking place during melanogenesis
[44]. To these recognized sources of prooxidant equiv-
alents, our present data allow the addition of membrane
GGT activity. GGT-mediated prooxidant reactions
appear to represent an additional mechanism by which
tumor cells expressing significant levels of enzyme can
access an improved supply of ascorbate from the
medium. This so far unrecognized ability could contrib-
ute to malignant phenotype, by increasing resistance of
cancer cells to prooxidant agents and chemotherapeutic
drugs.
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AA—ascorbic acid
CAT—catalase
DHA—dehydroascorbic acid
DHAR—dehydroascorbate reductase
FT—ferritin
hTf—holo-transferrin
GGT—g-glutamyltransferase
gly-gly—glycyl-glycine
GSH—reduced glutathione
ROS—reactive oxygen species
SEB—serine/boric acid complex
SOD—superoxide dismutase
